Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris

Nahrisyah Nahrisyah; Kristo A. Nababan

doi:10.71197/jsocmed.v4i2.195

Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris

Nahrisyah Nahrisyah
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara
Kristo A. Nababan
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Sumatera Utara

Abstract

Introduction: Psoriasis vulgaris is a chronic inflammatory skin disorder characterized by the presence of scaly, red plaques. The severity of the condition is often evaluated using the Psoriasis Area and Severity Index (PASI), which quantifies the extent and severity of skin lesions. A treatment is considered successful when a PASI 75 is achieved, indicating a 75% reduction in the PASI score.

Case: A 26-year-old female presented with itchy and scaly red plaques covering nearly her entire body for the past month. Upon examination, her initial PASI score was 21.8. The patient was treated with a combination of systemic and topical therapies, resulting in a significant clinical improvement. Within two months, the patient achieved a PASI 75, demonstrating a 75% reduction in the PASI score.

Conclusion: This case underscores the importance of achieving PASI 75 as a critical treatment goal in both clinical practice and research. It highlights the potential of effective therapy in managing psoriasis vulgaris and serves as a guide for dermatologists in optimizing treatment strategies for psoriasis patient.

Similar Articles

Rahmah Evelin Lubis, Diza Tanzira, Nurhakiki Zahara Arif, Cardiovascular Disease with COVID-19 in Rural Area: Case Series , Journal of Society Medicine: Vol. 2 No. 6 (2023): June
Artha Wahyu Wardana, Muchammad Erias Erlangga, Management of Guillain-Barré Syndrome with Respiratory Distress in a Pregnant Woman: A Case Report , Journal of Society Medicine: Vol. 3 No. 1 (2024): January
Junius F. A. Simarmata, Kiking Ritarwan, Rabies Encephalitis: Fatal Yet Neglected, A Case Report , Journal of Society Medicine: Vol. 3 No. 2 (2024): February
Monica Tampubolon, Kiki M. Iqbal, R. A. Dwi Pujiastuti, Osmolarity Changes after Mannitol Administration in Cerebral Edema Patients , Journal of Society Medicine: Vol. 2 No. 7 (2023): July
Dia Tri Susanti, Gema Nazri Yanni, Johannes H. Saing, Erna Mutiara, Aridamuriany D. Lubis, Olga R. Siregar, Correlation of Fibrinogen Level with PELOD-2 Score As A Predictive Factor For Mortality in Pediatric Sepsis , Journal of Society Medicine: Vol. 2 No. 11 (2023): November
Romi Ridwan, Ezra Oktaliansyah, Case Series of Guillain Barre Syndrome with Plasmaparesis in The ICU Bandung Hospital , Journal of Society Medicine: Vol. 3 No. 4 (2024): April
Ade Nur Imansyah, Elvita Rahmi Daulay, Khairul Putra Surbakti, The Relationship between Age and Cerebral Atrophy on Head CT-Scan Examination at Haji Adam Malik General Hospital Medan , Journal of Society Medicine: Vol. 3 No. 5 (2024): May
Robert Sihombing, Osmond Muftilov Pison, Management of Patients with Guillain Barre Syndrome Accompanied by Ventilator Associated Pneumonia , Journal of Society Medicine: Vol. 3 No. 5 (2024): May
Utama Hadiputra Surbakti, R.A. Dwi Pujiastuti, Kiking Ritarwan, Associations between Depression and Anxiety with Sleep Quality in Post Stroke Patients , Journal of Society Medicine: Vol. 2 No. 3 (2023): March
Annisa Nidya Rahmatika Sitepu, Dharma Lindarto, Melati Silvanni Nasution, Lipid Profile in Confirmed Covid-19 Patients with Type 2 Diabetes Mellitus At Haji Adam Malik General Hospital Medan from March 2020 to December 2021 , Journal of Society Medicine: Vol. 2 No. 3 (2023): March

<< < 2 3 4 5 6 7 8 9 > >>

You may also start an advanced similarity search for this article.

PDF

Published at

28. February 2025
https://doi.org/10.71197/jsocmed.v4i2.195
Issue:

Vol. 4 No. 2 (2025): February
Section:

Articles
Keywords:

Psoriasis vulgaris Psoriasis area and severity index Treatment strategies
References:

Van de Kerkhof PCM, Nestle FO. Psoriasis. In: Bolognia JL, Schaffer JV, Cerroni L, editors. Dermatology. Elsevier. 2018; pp. 494-508.

Gudjonsson JE, Elder JT. Psoriasis. In: Kang S, Amagai M, Bruckner AL, Enk AH, Margolis DJ, McMichael AJ, Orringer JS, editors. Fitzpatrick's Dermatology. 9th ed. New York: McGraw-Hill Education. 2019; pp. 457-497.

Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: A review. JAMA. 2020; 323(19): 1945-1960.

Burden AD, Kirby B. Psoriasis and related disorders. In: Rook’s Textbook of Dermatology. 9th ed. 2016; pp. 1–64.

Petit RG, Cano A, Ortiz A, Espina M, Prat J, Muñoz M, et al. Psoriasis: From pathogenesis to pharmacological and nano-technological-based therapeutics. Int J Mol Sci. 2021; 22(1): 150.

Yamanaka K, Yamamoto O, Honda T. Pathophysiology of psoriasis: A review. J Dermatol. 2021; 48(6): 722-731.

Hanani NK, Ervianti E, Rahniayu A. Clinical profile of psoriasis vulgaris at Soetomo General Hospital, Surabaya. Health Nations. 2020; 4(9): 282-289.

Damayanti, Pratiwi KD, Nugroho WT. Profile of psoriasis vulgaris patients treated with methotrexate at Dr. Soetomo Hospital, Surabaya, 2017-2018. Jurnal Berkala Epidemiologi. 2021; 9(1): 70-78.

Naufal A, Damayanti, Kusumastuti EH, Hidayati AN. Risk factor profile and quality of life of psoriasis vulgaris. Periodical of Dermatology and Venereology. 2021; 33(2): 129-134.

Listiawan MY, Fadila A, Wiratama PA, et al. Evaluation of histopathology findings of clinically confirmed psoriasis vulgaris. Berk Ilmu Kesehat Kulit Kelamin. 2023; 35: 21-26.

Negrutiu M, Danescu S, Popa T, Focsan M, Vesa SC, Szasz F, et al. Imaging approach in the diagnostics and evaluation of the psoriasis plaque: A preliminary study and literature review. Diagnostics. 2024; 14(10): 969.

Susanto PM. Tatalaksana psoriasis eritroderma. Jurnal Medika Hutama. 2022; 03(02): 45-50.

Foley P, Gebauer K, Sullivan J, McMeniman E, Shumack S, Ng J, James A, et al. Australian consensus: Treatment goals for moderate to severe psoriasis in the era of targeted therapies—Adult patients. Australas J Dermatol. 2023; 64(4): 476-487.

Manchanda Y, De A, Das S, Chakraborty D. Disease assessment in psoriasis. Indian J Dermatol. 2023; 68(3): 278-281.

Kamiya K, Kishimoto M, Sungai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019; 20(1): 1-14.

Perdoski. Psoriasis. In: Widaty S, Soebono H, Nilasari H, Listiawan MY, Siswati AS, Triwahyudi D, et al., editors. Panduan Praktik Klinis bagi Dokter Spesialis Kulit dan Kelamin di Indonesia. Jakarta. 2022; pp. 230-241.

Rendon A, Schäkel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019; 20(6): 1475.

Abrouk M, Nakamura M, Zhu TH, Farahnik B, Koo J, Bhutani T. The impact of PASI 75 and PASI 90 on quality of life in moderate to severe psoriasis patients. J Dermatolog Treat. 2017; 28(6): 488-491.

Kurniawan K, Fahira A, Ramadan ET, Budianti WK. Low-calorie diet improves PASI score in psoriasis patients with obesity: An evidence-based case report. J Gen Proced Dermatol Venereol Indones. 2021; 5(3): 193-203.

Ramic L, Sator P. Topical treatment of psoriasis vulgaris. J Dtsch Dermatol Ges. 2023; 21(6): 631-642.
Share:

Z

Nahrisyah, N., & Nababan, K. A. (2025). Reduction of 75% in the Psoriasis Area and Severity Index (PASI) for Moderate-to-Severe Psoriasis Vulgaris. Journal of Society Medicine, 4(2), 50–54. https://doi.org/10.71197/jsocmed.v4i2.195